Records containing: Metabolic Dysfunction-associated Fatty Liver Disease
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-03-06An Observational Clinical Study on the Association of Intestinal Ruminococcus Gnavus and Its Derived Biogenic Amines With Metabolic Dysfunction-associated Fatty Liver Disease
-
CLINICAL_TRIALS study record update · 2025-07-25A Randomized, Controlled Study to Evaluate the Efficacy and Safety of Calculus Bovis Sativus in Adult Subjects With Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD)
-
CLINICAL_TRIALS study record update · 2025-02-12Association of High-sensitivity C-reactive Protein to Albumin Ratio with Metabolic Dysfunction-associated Fatty Liver Disease and Liver Fibrosis: a Cross-sectional Study
-
CLINICAL_TRIALS study record update · 2024-08-21Positive Association Between Ultrasonographic Fatty Liver Indicator and the Severity of Coronary Artery Disease
-
CLINICAL_TRIALS study record update · 2023-11-18Prospective Cohort Study on MAFLD-related Cirrhosis Prevention and Treatment Strategies
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2023-09-29The Potential Value and Impact of Diagnostic Biomarkers for MAFLD Using Machine Learning Methods
-
CLINICAL_TRIALS study record update · 2023-02-21NMR-based Metabolic Profiling Identifies High Risk of Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Patients With Advanced Fibrosis: An Observational, Multi-center Study